Physician profile
Fay Stearns
NPI 1366745788
$1,502.44
in general payments reported to CMS, 2019-2025
9 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $248 · 2023: $251 · 2024: $593 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,254.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.97 | 2023-2025 | |
| Revance Therapeutics, INC. | $311.04 | 2025 | Daxxify |
| Boston Scientific Corporation | $147.87 | 2024 | Watchman Flx |
| Galderma Laboratories, L.P. | $147.14 | 2024 | Dysport |
| Medtronic, INC. | $129.70 | 2024 | Linq II |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Chiesi USA, INC. | $124.81 | 2023 | Cleviprex |
| Horizon Therapeutics Plc | $123.00 | 2022 | |
| Merz North America, INC. | $71.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fay Stearns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.